Elixiron Immunotherapeutics (Hong Kong) Ltd.
2 clinical trials · Sponsor
◉ Watch Elixiron Immunotherapeutics (Hong Kong) Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients (NCT07223229) | Elixiron Immunotherapeutics (Hong Kong) Ltd. | 2025-12-30 |
| First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers (NCT04994912) | Elixiron Immunotherapeutics (Hong Kong) Ltd. | 2021-10-01 |
Track Elixiron Immunotherapeutics (Hong Kong) Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.